Headway-DLB, based in New York, is dedicated to breaking the boundaries of gene therapy in the treatment of serious neurodegenerative diseases. With a sense of urgency, they develop and deliver innovative gene therapies that aim to transform patient care.
At Sio, their mission is to combine cutting-edge research and technology to create impactful treatments that address the complexities of neurodegenerative disorders. Through their commitment to innovation, they strive to revolutionize the field of gene therapy.
Generated from their website's infomation